BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dellon ES, Hirano I. Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology. 2018;154:319-332.e3. [PMID: 28774845 DOI: 10.1053/j.gastro.2017.06.067] [Cited by in Crossref: 200] [Cited by in F6Publishing: 173] [Article Influence: 40.0] [Reference Citation Analysis]
Number Citing Articles
1 Dhar A, Haboubi HN, Attwood SE, Auth MKH, Dunn JM, Sweis R, Morris D, Epstein J, Novelli MR, Hunter H, Cordell A, Hall S, Hayat JO, Kapur K, Moore AR, Read C, Sami SS, Turner PJ, Trudgill NJ. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut 2022:gutjnl-2022-327326. [PMID: 35606089 DOI: 10.1136/gutjnl-2022-327326] [Reference Citation Analysis]
2 Ghisa M, Laserra G, Maniero D, Marabotto E, Barberio B, Pelizzaro F, Barbuscio I, Zingone F, Savarino V, Savarino E. Eosinophilic esophagitis: from pathophysiology to management. Minerva Gastroenterol (Torino) 2022;68:40-8. [PMID: 33267562 DOI: 10.23736/S2724-5985.20.02780-4] [Reference Citation Analysis]
3 Cafone J, Capucilli P, Hill DA, Spergel JM. Eosinophilic esophagitis during sublingual and oral allergen immunotherapy. Curr Opin Allergy Clin Immunol 2019;19:350-7. [PMID: 31058677 DOI: 10.1097/ACI.0000000000000537] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
4 Tamarit-sebastian S, Ferrer-soler FM, Lucendo AJ. Current options and investigational drugs for the treatment of eosinophilic esophagitis. Expert Opinion on Investigational Drugs. [DOI: 10.1080/13543784.2022.2033207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Johansson MW, McKernan EM, Fichtinger PS, Angulo EL, Bagley JL, Lee KE, Evans MD, Lomeli LD, Mosher DF, Cook SM, Gaumnitz EA, Mathur SK. αIIb-Integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis. J Allergy Clin Immunol 2020;145:1699-701. [PMID: 32004525 DOI: 10.1016/j.jaci.2020.01.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Talley NJ, Walker MM. The Rise and Rise of Eosinophilic Gut Diseases Including Eosinophilic Esophagitis Is Probably Not Explained by the Disappearance of Helicobacter pylori, so Who or What's to Blame? American Journal of Gastroenterology 2018;113:941-4. [DOI: 10.1038/s41395-018-0125-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ruffner MA, Spergel JM. Pediatric eosinophilic esophagitis: updates for the primary care setting. Curr Opin Pediatr 2018;30:829-36. [PMID: 30239371 DOI: 10.1097/MOP.0000000000000698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
8 Thakkar KP, Fowler M, Keene S, Iuga A, Dellon ES. Long-term efficacy of proton pump inhibitors as a treatment modality for eosinophilic esophagitis. Dig Liver Dis 2022:S1590-8658(22)00209-2. [PMID: 35410852 DOI: 10.1016/j.dld.2022.03.006] [Reference Citation Analysis]
9 Avinashi V, Al Yarubi Z, Soller L, Lam G, Chan ES. Oral peanut immunotherapy acutely unmasking eosinophilic esophagitis with an esophageal stricture. Ann Allergy Asthma Immunol 2021;127:691-2. [PMID: 34517129 DOI: 10.1016/j.anai.2021.09.001] [Reference Citation Analysis]
10 Röjler L, Garber JJ, Roelstraete B, Walker MM, Ludvigsson JF. Mortality in Eosinophilic Esophagitis - a nationwide, population-based matched cohort study from 2005 to 2017. Ups J Med Sci 2021;126. [PMID: 34540144 DOI: 10.48101/ujms.v126.7688] [Reference Citation Analysis]
11 Nance D, Rappazzo KM, Jensen ET, Hoffman K, Cotton CC, Krajewski AK, Turner KO, Genta RM, Lobdell DT, Dellon ES. Increased risk of eosinophilic esophagitis with poor environmental quality as measured by the Environmental Quality Index. Dis Esophagus 2021:doab041. [PMID: 34155508 DOI: 10.1093/dote/doab041] [Reference Citation Analysis]
12 Sohn JK, Barnes BH, Al-Hazaymeh A, Sauer BG, McGowan EC. High prevalence of developmental disorders in pediatric eosinophilic esophagitis (EoE): A single-center observational study. J Allergy Clin Immunol Pract 2021;9:1032-1034.e1. [PMID: 33010523 DOI: 10.1016/j.jaip.2020.09.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lucendo AJ. Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies. Expert Rev Clin Immunol 2020;16:63-77. [PMID: 31842634 DOI: 10.1080/1744666X.2019.1705784] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yamamoto M, Nagashima S, Yamada Y, Murakoshi T, Shimoyama Y, Takahashi S, Seki H, Kobayashi T, Hara Y, Tadaki H, Ishimura N, Ishihara S, Kinoshita Y, Morita H, Ohya Y, Saito H, Matsumoto K, Nomura I. Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey. J Allergy Clin Immunol Pract 2021:S2213-2198(21)00714-5. [PMID: 34214704 DOI: 10.1016/j.jaip.2021.06.026] [Reference Citation Analysis]
15 Visaggi P, Savarino E, Sciume G, Chio TD, Bronzini F, Tolone S, Frazzoni M, Pugno C, Ghisa M, Bertani L, Bellini M, Savarino V, Peroni D, Marchi S, de Bortoli N. Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults. Therap Adv Gastroenterol 2021;14:1756284820980860. [PMID: 33613690 DOI: 10.1177/1756284820980860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Herman SM, Zaborniak K, Bernstein CN. Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind? Inflamm Bowel Dis 2021:izab183. [PMID: 34473278 DOI: 10.1093/ibd/izab183] [Reference Citation Analysis]
17 Collison AM, Sokulsky LA, Nightingale S, Percival E, LeFevre A, Meredith J, Krauss S, Foster PS, Mattes J. In vivo targeting of miR-223 in experimental eosinophilic oesophagitis. Clin Transl Immunology 2020;9:e1210. [PMID: 33282292 DOI: 10.1002/cti2.1210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kim JP, Weingart G, Hiramoto B, Gregory DL, Gonsalves N, Hirano I. Clinical outcomes of adults with eosinophilic esophagitis with severe stricture. Gastrointestinal Endoscopy 2020;92:44-53. [DOI: 10.1016/j.gie.2020.01.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
19 Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-Katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, McGowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Gastroenterology 2022:S0016-5085(22)00287-6. [PMID: 35606197 DOI: 10.1053/j.gastro.2022.03.025] [Reference Citation Analysis]
20 Gómez-Aldana A, Jaramillo-Santos M, Delgado A, Jaramillo C, Lúquez-Mindiola A. Eosinophilic esophagitis: Current concepts in diagnosis and treatment. World J Gastroenterol 2019; 25(32): 4598-4613 [PMID: 31528089 DOI: 10.3748/wjg.v25.i32.4598] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
21 Eke R, Dellon ES. Hospitalization trends and determinants of inpatient costs for eosinophilic esophagitis patients in the United States: results from the Nationwide Inpatient Sample analysis. Ann Gastroenterol 2021;34:643-50. [PMID: 34475734 DOI: 10.20524/aog.2021.0638] [Reference Citation Analysis]
22 Chehade M, Brown S. Elimination diets for eosinophilic esophagitis: making the best choice. Expert Review of Clinical Immunology 2020;16:679-87. [DOI: 10.1080/1744666x.2020.1801419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
23 Chang NC, Thakkar KP, Ketchem CJ, Eluri S, Reed CC, Dellon ES. A Gap in Care Leads to Progression of Fibrosis in Eosinophilic Esophagitis Patients. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01141-1. [PMID: 34718172 DOI: 10.1016/j.cgh.2021.10.028] [Reference Citation Analysis]
24 Greenberg S, Chang NC, Corder SR, Reed CC, Eluri S, Dellon ES. Dilation-predominant approach versus routine care in patients with difficult-to-treat eosinophilic esophagitis: a retrospective comparison. Endoscopy 2021. [PMID: 33910259 DOI: 10.1055/a-1493-5627] [Reference Citation Analysis]
25 Buck E, Ocholi A, Moolenschot KL, Kapoor R, Perkin M, Wells R. Eosinophilic Oesophagitis: Significantly increasing prevalence in a tertiary London Paediatric Gastro-Intestinal and Allergy department. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101958] [Reference Citation Analysis]
26 Facchin S, Calgaro M, Pandolfo M, Caldart F, Ghisa M, Greco E, Sattin E, Valle G, Dellon E, Vitulo N, Savarino EV. Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects. Aliment Pharmacol Ther 2022. [PMID: 35715947 DOI: 10.1111/apt.17091] [Reference Citation Analysis]
27 Votto M, De Filippo M, Lenti MV, Rossi CM, Di Sabatino A, Marseglia GL, Licari A. Diet Therapy in Eosinophilic Esophagitis. Focus on a Personalized Approach. Front Pediatr 2022;9:820192. [DOI: 10.3389/fped.2021.820192] [Reference Citation Analysis]
28 Mehr S, Brown-Whitehorn T. What do allergists in practice need to know about non-IgE-mediated food allergies. Ann Allergy Asthma Immunol 2019;122:589-97. [PMID: 30935977 DOI: 10.1016/j.anai.2019.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
29 Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Galanko JA, Baron JA, Shaheen NJ. Rapid Recurrence of Eosinophilic Esophagitis Activity After Successful Treatment in the Observation Phase of a Randomized, Double-Blind, Double-Dummy Trial. Clin Gastroenterol Hepatol. 2020;18:1483-1492.e2. [PMID: 31499249 DOI: 10.1016/j.cgh.2019.08.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
30 Lucendo AJ, Molina-infante J. Dietary therapy for eosinophilic esophagitis: chances and limitations in the clinical practice. Expert Review of Gastroenterology & Hepatology 2020;14:941-52. [DOI: 10.1080/17474124.2020.1791084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chang JW, Haller E, Dellon ES. Dietary Management of Eosinophilic Esophagitis: Man Versus Food or Food Versus Man? Gastroenterol Clin North Am 2021;50:59-75. [PMID: 33518169 DOI: 10.1016/j.gtc.2020.10.009] [Reference Citation Analysis]
32 Fujiwara Y. Symptom-based diagnostic approach for eosinophilic esophagitis. J Gastroenterol 2020;55:833-45. [PMID: 32720208 DOI: 10.1007/s00535-020-01701-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
33 Oliva S, Rossetti D, Papoff P, Tiberti A, Mallardo S, Volpe D, Ruggiero C, Russo G, Vezzoli D, Isoldi S, Cucchiara S. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis. Dig Dis Sci 2019;64:1571-8. [PMID: 30659470 DOI: 10.1007/s10620-018-5449-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Silva FMCE, de Oliveira EE, Ambrósio MGE, Ayupe MC, de Souza VP, Menegati LM, Reis DRL, Machado MA, Macedo GC, Ferreira AP. Disodium cromoglycate treatment reduces TH2 immune response and immunohistopathological features in a murine model of Eosinophilic Esophagitis. Int Immunopharmacol 2020;83:106422. [PMID: 32251959 DOI: 10.1016/j.intimp.2020.106422] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Eluri S, Tappata M, Huang KZ, Koutlas NT, Robey BS, Fan C, Reed CC, Shaheen NJ, Dellon ES. Distal esophagus is the most commonly involved site for strictures in patients with eosinophilic esophagitis. Diseases of the Esophagus 2020;33:doz088. [DOI: 10.1093/dote/doz088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
36 Schoepfer A, Blanchard C, Dawson H, Lucendo A, Mauro A, Ribi C, Safroneeva E, Savarino EV, Penagini R. Eosinophilic esophagitis: latest insights from diagnosis to therapy. Ann N Y Acad Sci 2018;1434:84-93. [DOI: 10.1111/nyas.13731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
37 Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NM, Akinlade B, Stahl N, Yancopoulos GD, Radin A. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. Gastroenterology 2020;158:111-122.e10. [DOI: 10.1053/j.gastro.2019.09.042] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 43.0] [Reference Citation Analysis]
38 Collins MH, Dellon ES, Katzka DA, Hirano I, Williams J, Lan L. Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results: Analyses From a 12-Week, Phase 2, Randomized, Placebo-controlled Trial. Am J Surg Pathol. 2019;43:1501-1509. [PMID: 31498177 DOI: 10.1097/pas.0000000000001361] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
39 Reed CC, Dellon ES. Eosinophilic Esophagitis. Med Clin North Am 2019;103:29-42. [PMID: 30466674 DOI: 10.1016/j.mcna.2018.08.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
40 Dellon ES. No Maintenance, No Gain in Long-term Treatment of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2019;17:397-9. [PMID: 30678839 DOI: 10.1016/j.cgh.2018.07.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Anderson J, Moonie S, Hogan MB, Scherr R, Allenback G. Eosinophilic esophagitis: comorbidities and atopic disease in Nevada. Dis Esophagus 2020;33:doz105. [PMID: 32052023 DOI: 10.1093/dote/doz105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Plundrich NJ, Smith AR, Borst LB, Snider DB, Käser T, Dellon ES, Blikslager AT, Odle J, Lila MA, Laster SM. Oesophageal eosinophilia accompanies food allergy to hen egg white protein in young pigs. Clin Exp Allergy 2020;50:95-104. [PMID: 31702085 DOI: 10.1111/cea.13527] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
43 Hillman L, Donohue S, Broman AT, Hoversten P, Gaumnitz E, Lomeli L. Empiric proton pump inhibitor therapy after esophageal food impaction may mask eosinophilic esophagitis diagnosis at follow-up. Dis Esophagus 2021:doab030. [PMID: 33987650 DOI: 10.1093/dote/doab030] [Reference Citation Analysis]
44 Bennett Murphy LM, O’gorman M, Fitzgerald S, Peterson K, Robson J. Quality of life in children and adolescents with eosinophilic esophagitis. Children's Health Care. [DOI: 10.1080/02739615.2022.2079510] [Reference Citation Analysis]
45 Huguenot M, Bruhm AC, Essig M. Histological remission of eosinophilic esophagitis under asthma therapy with IL-5 receptor monoclonal antibody: A case report. World J Clin Cases 2022; 10(14): 4502-4508 [DOI: 10.12998/wjcc.v10.i14.4502] [Reference Citation Analysis]
46 Chen JW. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches. Nutr Clin Pract 2020;35:835-47. [PMID: 32822071 DOI: 10.1002/ncp.10571] [Reference Citation Analysis]
47 Ma C, Schoepfer AM, Dellon ES, Bredenoord AJ, Chehade M, Collins MH, Feagan BG, Furuta GT, Gupta SK, Hirano I, Jairath V, Katzka DA, Pai RK, Rothenberg ME, Straumann A, Aceves SS, Alexander JA, Arva NC, Atkins D, Biedermann L, Blanchard C, Cianferoni A, Ciriza de Los Rios C, Clayton F, Davis CM, de Bortoli N, Dias JA, Falk GW, Genta RM, Ghaffari G, Gonsalves N, Greuter T, Hopp R, Hsu Blatman KS, Jensen ET, Johnston D, Kagalwalla AF, Larsson HM, Leung J, Louis H, Masterson JC, Menard-Katcher C, Menard-Katcher PA, Moawad FJ, Muir AB, Mukkada VA, Penagini R, Pesek RD, Peterson K, Putnam PE, Ravelli A, Savarino EV, Schlag C, Schreiner P, Simon D, Smyrk TC, Spergel JM, Taft TH, Terreehorst I, Vanuytsel T, Venter C, Vieira MC, Vieth M, Vlieg-Boerstra B, von Arnim U, Walker MM, Wechsler JB, Woodland P, Woosley JT, Yang GY, Zevit N, Safroneeva E; COREOS Collaborators:. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS). J Allergy Clin Immunol 2021:S0091-6749(21)01059-9. [PMID: 34242635 DOI: 10.1016/j.jaci.2021.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
48 Wartak A, Garber JG, Yuan Q, Shreffler WG, Hesterberg PE, Katz AJ, Osman H, Leung HM, Gao A, Otuya DO, Grant C, Gardecki JA, Nishioka N, Tearney GJ, Apiou-sbirlea G. In vivo optical endomicroscopy: two decades of translational research towards next generation diagnosis of eosinophilic esophagitis. transl med commun 2021;6. [DOI: 10.1186/s41231-020-00080-z] [Reference Citation Analysis]
49 Krarup AL, Drewes AM, Ejstrud P, Laurberg PT, Vyberg M. Implementation of a biopsy protocol to improve detection of esophageal eosinophilia: a Danish registry-based study. Endoscopy 2021;53:15-24. [PMID: 32757199 DOI: 10.1055/a-1206-0852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
50 Son MY, Kim SE, Park SJ, Park MI, Moon W, Kim JH, Jung K, Choi GS, Im SI. Eosinophilic Esophagitis with Angina Pectoris. Korean J Gastroenterol 2020;76:78-82. [PMID: 32839370 DOI: 10.4166/kjg.2020.76.2.78] [Reference Citation Analysis]
51 Eluri S, Corder SR, Kim E, Tappata M, Reed CC, Shaheen NJ, Dellon ES. Clinical features and time trends associated with an endoscopically normal esophagus in active eosinophilic esophagitis. Endoscopy 2021;53:886-92. [DOI: 10.1055/a-1284-5891] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Haruma K. Eosinophilic esophagitis: time for clinical practice. Esophagus 2019;16:331-2. [PMID: 31385096 DOI: 10.1007/s10388-019-00687-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Kumar S, Choi SS, Gupta SK. Eosinophilic esophagitis: current status and future directions. Pediatr Res 2020;88:345-7. [PMID: 31962343 DOI: 10.1038/s41390-020-0770-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Miehlke S, von Arnim U, Schlag C, Labenz J, Madisch A. [Treatment of eosinophilic esophagitis - advancements and perspectives]. Z Gastroenterol 2021;59:869-78. [PMID: 34157757 DOI: 10.1055/a-1429-4192] [Reference Citation Analysis]
55 Dellon ES. Optimizing the Endoscopic Examination in Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2021;19:2489-2492.e1. [PMID: 34332949 DOI: 10.1016/j.cgh.2021.07.011] [Reference Citation Analysis]
56 Cavalli E, Brusaferro A, Pieri ES, Cozzali R, Farinelli E, De' Angelis GL, Esposito S. Eosinophilic esophagitis in children: doubts and future perspectives. J Transl Med 2019;17:262. [PMID: 31399124 DOI: 10.1186/s12967-019-2014-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Cianferoni A, Jensen E, Davis CM. The Role of the Environment in Eosinophilic Esophagitis. J Allergy Clin Immunol Pract 2021;9:3268-74. [PMID: 34507708 DOI: 10.1016/j.jaip.2021.07.032] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology 2022:S0016-5085(21)04083-X. [PMID: 35183361 DOI: 10.1053/j.gastro.2021.12.247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
59 Spechler SJ. Speculation as to why the Frequency of Eosinophilic Esophagitis Is Increasing. Curr Gastroenterol Rep 2018;20:26. [PMID: 29767340 DOI: 10.1007/s11894-018-0633-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
60 Rojas Pineda NA, Morfin Maciel BM, Chanona-Vilchis J. Throat clearing as the only symptom of eosinophilic esophagitis: A case report. Rev Gastroenterol Mex (Engl Ed) 2020;85:216-8. [PMID: 31248661 DOI: 10.1016/j.rgmx.2019.04.003] [Reference Citation Analysis]
61 Savarino EV, Iovino P, Santonicola A, Ghisa M, Laserra G, Barberio B, Maniero D, Lorenzon G, Ciacci C, Savarino V, Zingone F. Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak. J Clin Med 2020;9:E2011. [PMID: 32604895 DOI: 10.3390/jcm9062011] [Reference Citation Analysis]
62 Tambucci R, Rea F, Angelino G, Malamisura M, Mennini M, Riccardi C, Farello G, Valfré L, Dall'Oglio L, Markowitz JE, Fiocchi AG, De Angelis P. Eosinophilic esophagitis in esophageal atresia: Tertiary care experience of a "selective" approach for biopsy sampling. World Allergy Organ J 2020;13:100116. [PMID: 32256942 DOI: 10.1016/j.waojou.2020.100116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Spechler SJ. Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations. J Gastroenterol 2019;54:837-44. [PMID: 31342146 DOI: 10.1007/s00535-019-01604-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
64 Shoda T, Wen T, Caldwell JM, Ben-Baruch Morgenstern N, Osswald GA, Rochman M, Mack LE, Felton JM, Abonia JP, Arva NC, Atkins D, Bonis PA, Capocelli KE, Collins MH, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Leung J, Menard-Katcher PA, Mukkada VA, Putnam PE, Rudman Spergel AK, Spergel JM, Wechsler JB, Yang GY, Aceves SS, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) Investigators Group. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk. Gastroenterology 2021:S0016-5085(21)03653-2. [PMID: 34687736 DOI: 10.1053/j.gastro.2021.10.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
65 Alterio T, Cardile S, Trayers C, Valenti S, Loddo I, Mardare R, Mosca A, Nobili V. Eosinophilic esophagitis in children: current knowledge to open new horizons: Eosinophilic esophagitis in pediatrics. Scandinavian Journal of Gastroenterology 2019;54:822-9. [DOI: 10.1080/00365521.2019.1641214] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Votto M, Marseglia GL, De Filippo M, Brambilla I, Caimmi SME, Licari A. Early Life Risk Factors in Pediatric EoE: Could We Prevent This Modern Disease? Front Pediatr 2020;8:263. [PMID: 32548083 DOI: 10.3389/fped.2020.00263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Ruffner MA, Zhang Z, Maurer K, Muir AB, Cianferoni A, Sullivan KE, Spergel JM. RNA sequencing identifies global transcriptional changes in peripheral CD4+ cells during active oesophagitis and following epicutaneous immunotherapy in eosinophilic oesophagitis. Clin Transl Immunology 2021;10:e1314. [PMID: 34322233 DOI: 10.1002/cti2.1314] [Reference Citation Analysis]
68 Thanawala SU, Beveridge CA, Muir AB, Strobel MJ, Westcott-Chavez A, Serper M, Yang YX, Lynch KL. Hashing out current social media use in eosinophilic esophagitis. Dis Esophagus 2021;34:doab059. [PMID: 34491314 DOI: 10.1093/dote/doab059] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Sawada A, Hashimoto A, Uemura R, Otani K, Tanaka F, Nagami Y, Yamagami H, Tanigawa T, Watanabe T, Fujiwara Y. Association between endoscopic findings of eosinophilic esophagitis and responsiveness to proton pump inhibitors. Endosc Int Open 2019;7:E433-9. [PMID: 30931374 DOI: 10.1055/a-0859-7276] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
70 Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, Wang K, Greenhawt M, Falck-Ytter YT; AGA Institute Clinical Guidelines Committee., Joint Task Force on Allergy-Immunology Practice Parameters. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Ann Allergy Asthma Immunol 2020;124:416-23. [PMID: 32336462 DOI: 10.1016/j.anai.2020.03.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
71 Savarino EV, Iovino P, Santonicola A, Ghisa M, Laserra G, Barberio B, Maniero D, Lorenzon G, Ciacci C, Savarino V, Zingone F. Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak. J Clin Med 2020;9:E2011. [PMID: 32604895 DOI: 10.3390/jcm9062011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
72 Rodrigo-Muñoz JM, Gil-Martínez M, Sastre B, Del Pozo V. Emerging Evidence for Pleiotropism of Eosinophils. Int J Mol Sci 2021;22:7075. [PMID: 34209213 DOI: 10.3390/ijms22137075] [Reference Citation Analysis]
73 Hirano I, Furuta GT. Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis. Gastroenterology 2020;158:840-51. [PMID: 31836530 DOI: 10.1053/j.gastro.2019.09.052] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
74 Robson J, Laborda T, Fitzgerald S, Andersen J, Peterson K, O'Gorman M, Guthery S, Bennett-Murphy L. Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis. J Pediatr Gastroenterol Nutr 2019;69:57-60. [PMID: 30889128 DOI: 10.1097/MPG.0000000000002323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
75 Dellon ES. Cost-effective care in eosinophilic esophagitis. Ann Allergy Asthma Immunol 2019;123:166-72. [PMID: 31009702 DOI: 10.1016/j.anai.2019.04.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
76 Ghoz H, Stancampiano FF, Valery JR, Nordelo K, Malviya B, Lacy BE, Francis D, DeVault K, Bouras E, Krishna M, Palmer WC. Extent of eosinophilic esophagitis predicts response to treatment. Endosc Int Open 2021;9:E1234-42. [PMID: 34447870 DOI: 10.1055/a-1492-2650] [Reference Citation Analysis]
77 Ferrari D, Siboni S, Riva CG, Aiolfi A, Panici Tonucci T, Asti E, Bonavina L. Esophageal foreign bodies: observational cohort study and factors associated with recurrent impaction. Eur J Gastroenterol Hepatol 2020;32:827-31. [PMID: 32243348 DOI: 10.1097/MEG.0000000000001717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Ruffner MA, Cianferoni A. Phenotypes and endotypes in eosinophilic esophagitis. Ann Allergy Asthma Immunol 2020;124:233-9. [PMID: 31862435 DOI: 10.1016/j.anai.2019.12.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
79 Madison JM, Bhardwaj V, Braskett M. Strategy for Food Reintroduction Following Empiric Elimination and Elemental Dietary Therapy in the Treatment of Eosinophilic Gastrointestinal Disorders. Curr Gastroenterol Rep 2020;22. [DOI: 10.1007/s11894-020-00758-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Juel J. Debut of Gastroesophageal Reflux Concomitant with Administration of Sublingual Immunotherapy. Case Rep Gastrointest Med 2017;2017:8905372. [PMID: 29109876 DOI: 10.1155/2017/8905372] [Reference Citation Analysis]
81 Thaker AI, Melo DM, Samandi LZ, Huang R, Park JY, Cheng E. Esophageal Fibrosis in Eosinophilic Gastrointestinal Diseases. J Pediatr Gastroenterol Nutr 2021;72:392-7. [PMID: 33230074 DOI: 10.1097/MPG.0000000000002997] [Reference Citation Analysis]
82 Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, Wang K, Greenhawt M, Falck-Ytter YT; AGA Institute Clinical Guidelines Committee., Joint Task Force on Allergy-Immunology Practice Parameters. AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology 2020;158:1776-86. [PMID: 32359562 DOI: 10.1053/j.gastro.2020.02.038] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 22.0] [Reference Citation Analysis]
83 Limketkai BN, Shah SC, Hirano I, Bellaguarda E, Colombel JF. Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis. Gut 2019;68:2152-60. [PMID: 30923072 DOI: 10.1136/gutjnl-2018-318074] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
84 Odiase E, Zhang X, Chang Y, Nelson M, Balaji U, Gu J, Zhang Q, Pan Z, Spechler SJ, Souza RF. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump. Gastroenterology 2021;160:2072-2088.e6. [PMID: 33581123 DOI: 10.1053/j.gastro.2021.02.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
85 Rajani PS, Martin H, Groetch M, Järvinen KM. Presentation and Management of Food Allergy in Breastfed Infants and Risks of Maternal Elimination Diets. The Journal of Allergy and Clinical Immunology: In Practice 2020;8:52-67. [DOI: 10.1016/j.jaip.2019.11.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
86 Wasuwanich P, Batsis I, Thawillarp S, Alford MK, Mogul D, Wood RA, Karnsakul W. Post-transplant eosinophilic gastrointestinal disorders and lymphoproliferative disorder in pediatric liver transplant recipients on tacrolimus. Transpl Immunol 2021;68:101438. [PMID: 34320385 DOI: 10.1016/j.trim.2021.101438] [Reference Citation Analysis]
87 de Rooij WE, Barendsen ME, Warners MJ, van Rhijn BD, Verheij J, Bruggink AH, Bredenoord AJ. Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register-based pathology cohort. Neurogastroenterol Motil 2021;33:e14072. [PMID: 33426755 DOI: 10.1111/nmo.14072] [Reference Citation Analysis]
88 Keim VJ, Lutterer A, Geddert H, Gossner L. [Intramural esophageal abscess as a complication of an eosinophilic esophagitis]. Z Gastroenterol 2021;59:1078-82. [PMID: 34638154 DOI: 10.1055/a-1589-6806] [Reference Citation Analysis]
89 Doulberis M, Kountouras J, Rogler G. Reconsidering the "protective" hypothesis of Helicobacter pylori infection in eosinophilic esophagitis. Ann N Y Acad Sci 2020;1481:59-71. [PMID: 32770542 DOI: 10.1111/nyas.14449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Miehlke S, Schlag C, Lucendo AJ, Biedermann L, Vaquero CS, Schmoecker C, Hayat J, Hruz P, Ciriza de Los Rios C, Bredenoord AJ, Vieth M, Schoepfer A, Attwood S, Mueller R, Burrack S, Greinwald R, Straumann A; International EOS-2 Study Group. Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6-week open-label trial of the EOS-2 Programme. United European Gastroenterol J 2022;10:330-43. [PMID: 35412032 DOI: 10.1002/ueg2.12220] [Reference Citation Analysis]
91 Dellon ES, Woosley JT, McGee SJ, Moist SE, Shaheen NJ. Utility of major basic protein, eotaxin-3, and mast cell tryptase staining for prediction of response to topical steroid treatment in eosinophilic esophagitis: analysis of a randomized, double-blind, double dummy clinical trial. Dis Esophagus 2020;33:doaa003. [PMID: 32193541 DOI: 10.1093/dote/doaa003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Owaki T, Sato H, Horigome R, Hashimoto S, Honma T, Terai S. Eosinophilic esophagitis after total gastrectomy treated with proton pump inhibitors: a case report. Clin J Gastroenterol 2019;12:420-3. [DOI: 10.1007/s12328-019-00960-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 Ghosh G, Parra C, Cressey B, Zippin J, Crawford C. Clinical, Endoscopic, and Histologic Benefit With Comprehensive Type IV Hypersensitivity Patch Testing in Adults With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2021;19:2667-2669.e3. [PMID: 33130008 DOI: 10.1016/j.cgh.2020.10.044] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Barni S, Arasi S, Mastrorilli C, Pecoraro L, Giovannini M, Mori F, Liotti L, Saretta F, Castagnoli R, Caminiti L, Cianferoni A, Novembre E. Pediatric eosinophilic esophagitis: a review for the clinician. Ital J Pediatr 2021;47:230. [PMID: 34809686 DOI: 10.1186/s13052-021-01178-2] [Reference Citation Analysis]
95 Corder SR, Tappata M, Shaheen O, Cotton CC, Jensen ET, Dellon ES. Relationship Between Housing Components and Development of Eosinophilic Esophagitis. Dig Dis Sci 2020;65:3624-30. [PMID: 31970609 DOI: 10.1007/s10620-020-06063-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
96 Dellon ES, Woosley JT, Arrington A, McGee SJ, Covington J, Moist SE, Gebhart JH, Tylicki AE, Shoyoye SO, Martin CF, Galanko JA, Baron JA, Shaheen NJ. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial. Gastroenterology. 2019;157:65-73.e5. [PMID: 30872104 DOI: 10.1053/j.gastro.2019.03.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
97 Lee K, Furuta GT, Nguyen N. Eosinophilic Esophagitis Is an Underlying Cause for Gastrointestinal Concerns in Children. Front Pediatr 2018;6:113. [PMID: 29780792 DOI: 10.3389/fped.2018.00113] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
98 Philpott H, Dellon ES. The role of maintenance therapy in eosinophilic esophagitis: who, why, and how? J Gastroenterol 2018;53:165-71. [PMID: 29018965 DOI: 10.1007/s00535-017-1397-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
99 Ma C, Jairath V, Feagan BG, Guizzetti L, Zou G, McFarlane SC, Shackelton LM, Collins MH, Hirano I, de Rooij WE, Schaeffer DF, Pai RK, Bredenoord AJ, Dellon ES. Responsiveness of a Histologic Scoring System Compared With Peak Eosinophil Count in Eosinophilic Esophagitis. Am J Gastroenterol 2021. [PMID: 34797816 DOI: 10.14309/ajg.0000000000001571] [Reference Citation Analysis]
100 Kottyan L, Spergel JM, Cianferoni A. Immunology of the ancestral differences in eosinophilic esophagitis. Ann Allergy Asthma Immunol 2019;122:443-4. [PMID: 30414468 DOI: 10.1016/j.anai.2018.10.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
101 Hon E, Gupta SK. Gastrointestinal Food Allergies and Intolerances. Gastroenterol Clin North Am 2021;50:41-57. [PMID: 33518168 DOI: 10.1016/j.gtc.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Schreiner P, Safroneeva E, Rossel JB, Limacher A, Saner C, Greuter T, Schoepfer A, Straumann A, Biedermann L. Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01221-0. [PMID: 34798333 DOI: 10.1016/j.cgh.2021.11.009] [Reference Citation Analysis]
103 La Orden Izquierdo E, Mahillo-Fernández I, Fernández Fernández S, Barrio Torres J, Román Riechmann E, Gutiérrez Junquera C; Working group on Eosinophilic esophagitis of the “Gastrosuroeste group” in Madrid. Rising trend in p​ediatric eosinophilic esophagitis incidence in Spain: Results of a prospective study 2014-16. Pediatr Allergy Immunol 2021;32:1307-15. [PMID: 33934414 DOI: 10.1111/pai.13528] [Reference Citation Analysis]
104 McGowan EC, Aceves SS. Noninvasive tests for eosinophilic esophagitis: Ready for use? Ann Allergy Asthma Immunol 2021:S1081-1206(21)01175-3. [PMID: 34706258 DOI: 10.1016/j.anai.2021.10.025] [Reference Citation Analysis]
105 Lucendo AJ, Molina-infante J. Treatment of eosinophilic esophagitis with diets. Minerva Gastroenterol Dietol 2020;66. [DOI: 10.23736/s1121-421x.19.02634-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
106 Jensen ET, Aceves SS, Bonis PA, Bray K, Book W, Chehade M, Collins MH, Dellon ES, Falk GW, Gonsalves N, Gupta SK, Hirano I, Katzka DA, Kyle S, Mack D, Kodroff E, Leung J, Mukkada VA, Scott M, Paliana A, Sable K, Spergel JM, Strobel MJ, Krischer J, Rothenberg ME, Abonia P; CEGIR Investigator group. High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases. J Pediatr Gastroenterol Nutr 2020;71:524-9. [PMID: 32541201 DOI: 10.1097/MPG.0000000000002817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
107 Cotton CC, Durban R, Dellon ES. Illuminating Elimination Diets: Controversies Regarding Dietary Treatment of Eosinophilic Esophagitis. Dig Dis Sci 2019;64:1401-8. [PMID: 30927211 DOI: 10.1007/s10620-019-05602-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
108 Marella HK, Kothadia JP, Saleem N, Ali B, Abdel-Aziz Y, Mupparaju V, Oza T, Azouz A, Howden CW. A Patient with Eosinophilic Esophagitis and Herpes Simplex Esophagitis: A Case Report and Literature Review. Case Rep Gastrointest Med 2021;2021:5519635. [PMID: 34123440 DOI: 10.1155/2021/5519635] [Reference Citation Analysis]
109 Dellon ES, Shaheen O, Koutlas NT, Chang AO, Martin LJ, Rothenberg ME, Jensen ET. Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthood. Dis Esophagus 2021;34:doaa074. [PMID: 32766724 DOI: 10.1093/dote/doaa074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
110 de Rooij WE, Dellon ES, Parker CE, Feagan BG, Jairath V, Ma C, Bredenoord AJ. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review. Drugs 2019;79:1419-34. [DOI: 10.1007/s40265-019-01173-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
111 Oliva S, Azouz NP, Stronati L, Rothenberg ME. Recent advances in potential targets for eosinophilic esophagitis treatments. Expert Rev Clin Immunol 2020;16:421-8. [PMID: 32163308 DOI: 10.1080/1744666X.2020.1742110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 Beauchemin C, Castonguay A, Chan ES, Dellon ES, Feagan BG, Ma C, Waserman S, Cook J, Claveau D. Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility Analysis. Adv Ther 2021;38:5737-51. [PMID: 34699003 DOI: 10.1007/s12325-021-01957-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
113 Reddy A, Ashat D, Murali AR. Recent insights on the use of topical steroids in eosinophilic esophagitis. Expert Rev Gastroenterol Hepatol 2020;14:953-63. [PMID: 32567417 DOI: 10.1080/17474124.2020.1785869] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
114 Hold GL, Hansen R. Impact of the Gastrointestinal Microbiome in Health and Disease: Co-evolution with the Host Immune System. Curr Top Microbiol Immunol 2019;421:303-18. [PMID: 31123894 DOI: 10.1007/978-3-030-15138-6_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
115 Rossi CM, Lenti MV, Di Sabatino A. The need for a reliable non-invasive diagnostic biomarker for eosinophilic oesophagitis. The Lancet Gastroenterology & Hepatology 2022;7:202-3. [DOI: 10.1016/s2468-1253(21)00468-4] [Reference Citation Analysis]
116 Lenti MV, Savarino E, Mauro A, Penagini R, Racca F, Ghisa M, Laserra G, Merli S, Arsiè E, Longoni V, de Bortoli N, Sostilio A, Marabotto E, Ziola S, Vanoli A, Zingone F, Barberio B, Tolone S, Docimo L, Pellegatta G, Paoletti G, Ribolsi M, Repici A, Klersy C, Di Sabatino A. Diagnostic delay and misdiagnosis in eosinophilic oesophagitis. Dig Liver Dis 2021:S1590-8658(21)00268-1. [PMID: 34116974 DOI: 10.1016/j.dld.2021.05.017] [Reference Citation Analysis]
117 Fernandez-Becker NQ, Raja S, Scarpignato C, Lynch KL, Ahuja NK, Horsley-Silva JL. Eosinophilic esophagitis: updates on key unanswered questions. Ann N Y Acad Sci 2020;1481:30-42. [PMID: 32762154 DOI: 10.1111/nyas.14421] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Muir A, Falk GW. Eosinophilic Esophagitis: A Review. JAMA 2021;326:1310-8. [PMID: 34609446 DOI: 10.1001/jama.2021.14920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
119 Lyles JL, Martin LJ, Shoda T, Collins MH, Trimarchi MP, He H, Kottyan LC, Mukkada VA, Rothenberg ME. Very early onset eosinophilic esophagitis is common, responds to standard therapy, and demonstrates enrichment for CAPN14 genetic variants. J Allergy Clin Immunol 2021;147:244-254.e6. [PMID: 33446329 DOI: 10.1016/j.jaci.2020.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
120 Spechler SJ. Speculation as to why the Frequency of Eosinophilic Esophagitis Is Increasing. Curr Gastroenterol Rep. 2018;20:26. [PMID: 29767340 DOI: 10.1007/s11894-018-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Bartig KA, Lee KE, Mosher DF, Mathur SK, Johansson MW. Platelet association with leukocytes in active eosinophilic esophagitis. PLoS One 2021;16:e0250521. [PMID: 33891621 DOI: 10.1371/journal.pone.0250521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Okimoto E, Ishimura N, Adachi K, Kinoshita Y, Ishihara S, Tada T. Application of Convolutional Neural Networks for Diagnosis of Eosinophilic Esophagitis Based on Endoscopic Imaging. JCM 2022;11:2529. [DOI: 10.3390/jcm11092529] [Reference Citation Analysis]
123 Wilson JM, Li RC, McGowan EC. The Role of Food Allergy in Eosinophilic Esophagitis. J Asthma Allergy 2020;13:679-88. [PMID: 33364787 DOI: 10.2147/JAA.S238565] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
124 Choung RS, Saito YA, Schleck CD, Harmsen WS, Zinsmeister AR, Murray JA, Talley NJ. The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study. Mayo Clin Proc 2021;96:563-76. [PMID: 33673910 DOI: 10.1016/j.mayocp.2020.08.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Kim SJ, Park MI, Kim GH, Lee MW, Jung K, Lee J, Seol SY, Jee SR, Lee HS, Jang JS, Cha JH; Gyeongnam Society of Neurogastroenterology and Motility. Practice Patterns for Eosinophilic Esophagitis Patients in Busan and Gyeongnam: A Korean Multicenter Database Study. J Neurogastroenterol Motil 2021;27:71-7. [PMID: 32699187 DOI: 10.5056/jnm20069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Pytrus T, Akutko K, Kofla-dłubacz A, Stawarski A. Endoscopic Ultrasonography in Children with Eosinophilic Esophagitis—A Review. Pediatric Reports 2022;14:13-9. [DOI: 10.3390/pediatric14010003] [Reference Citation Analysis]
127 Roberts AJ, Day AS, Sinclair J, Dickson N, Porter J, Wellington G, Evans HM. Paediatric eosinophilic oesophagitis in New Zealand: A 3-year prospective study. J Paediatr Child Health 2021;57:234-8. [PMID: 32918510 DOI: 10.1111/jpc.15183] [Reference Citation Analysis]
128 Reed CC, Tappata M, Eluri S, Shaheen NJ, Dellon ES. Combination Therapy With Elimination Diet and Corticosteroids Is Effective for Adults With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol 2019;17:2800-2. [PMID: 30885887 DOI: 10.1016/j.cgh.2019.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
129 Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C, Paoletti G, Messina MR, Nappi E, Canonica GW, Repici A, Heffler E. Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets. Front Physiol 2022;12:815842. [DOI: 10.3389/fphys.2021.815842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Ketchem CJ, Thakkar KP, Xue A, Reddy S, Abramson L, Greenberg SB, Abichandani S, Miller TL, Chang NC, Eluri S, Reed CC, Dellon ES. Older patients with eosinophilic esophagitis have high treatment response to topical steroids. Dig Liver Dis 2021:S1590-8658(21)00809-4. [PMID: 34789398 DOI: 10.1016/j.dld.2021.10.004] [Reference Citation Analysis]
131 Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018;155:1022-1033.e10. [PMID: 30009819 DOI: 10.1053/j.gastro.2018.07.009] [Cited by in Crossref: 306] [Cited by in F6Publishing: 258] [Article Influence: 76.5] [Reference Citation Analysis]
132 Hiremath G, Sun L, Correa H, Acra S, Collins MH, Bonis P, Arva NC, Capocelli KE, Falk GW, King E, Gonsalves N, Gupta SK, Hirano I, Mukkada VA, Martin LJ, Putnam PE, Spergel JM, Wechsler JB, Yang GY, Aceves SS, Furuta GT, Rothenberg ME, Koyama T, Dellon ES. Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis. Am J Gastroenterol 2021. [PMID: 34932022 DOI: 10.14309/ajg.0000000000001587] [Reference Citation Analysis]
133 Votto M, De Filippo M, Caminiti L, Carella F, de Castro G, Landi M, Olcese R, Vernich M, Marseglia GL, Ciprandi G, Barberi S. Eosinophilic gastrointestinal disorders and allergen immunotherapy: Lights and shadows. Pediatr Allergy Immunol 2021;32:814-23. [PMID: 33503273 DOI: 10.1111/pai.13458] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Mehta P, Pan Z, Skirka S, Kwan BM, Menard-Katcher C. Medication Adherence Aligns with Age and a Behavioral Checklist but Not Symptoms or Quality of Life for Patients with Eosinophilic Esophagitis. J Pediatr 2021;235:246-252.e1. [PMID: 33811869 DOI: 10.1016/j.jpeds.2021.03.047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Dellon ES, Guo R, McGee SJ, Hamilton DK, Nicolai E, Covington J, Moist SE, Arrington A, Wright BL, Burks AW, Vickery BP, Kulis M. A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic Esophagitis. Clin Transl Gastroenterol 2019;10:e00099. [PMID: 31789931 DOI: 10.14309/ctg.0000000000000099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
136 Leiman DA, Kochar B, Posner S, Fan C, Patel A, Shaheen O, Keller CY, Koutlas NT, Eluri S, Dellon ES. A diagnosis of eosinophilic esophagitis is associated with increased life insurance premiums. Dis Esophagus 2018;31. [PMID: 29800243 DOI: 10.1093/dote/doy008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
137 Fernandez-Becker NQ. Eosinophilic Esophagitis: Incidence, Diagnosis, Management, and Future Directions. Gastroenterol Clin North Am 2021;50:825-41. [PMID: 34717873 DOI: 10.1016/j.gtc.2021.08.001] [Reference Citation Analysis]
138 Nhu QM, Moawad FJ. New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis. Curr Treat Options Gastroenterol 2019;17:48-62. [PMID: 30707411 DOI: 10.1007/s11938-019-00216-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
139 Capucilli P, Hill DA. Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications. Clin Rev Allergy Immunol 2019;57:111-27. [PMID: 30903437 DOI: 10.1007/s12016-019-08733-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
140 Cianferoni A, Warren CM, Brown-Whitehorn T, Schultz-Matney F, Nowak-Wegrzyn A, Gupta RS. Eosinophilic esophagitis and allergic comorbidities in a US-population-based study. Allergy 2020;75:1466-9. [PMID: 31846078 DOI: 10.1111/all.14148] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
141 Ozdogan E, Arikan C. Reply to Philpott and Dellon. Am J Gastroenterol 2021;116:1555. [PMID: 33811203 DOI: 10.14309/ajg.0000000000001253] [Reference Citation Analysis]
142 Spergel JM, Aceves SS, Kliewer K, Gonsalves N, Chehade M, Wechsler JB, Groetch M, Friedlander J, Dellon ES, Book W, Hirano I, Muir AB, Cianferoni A, Spencer L, Liacouras CA, Cheng E, Kottyan L, Wen T, Platts-Mills T, Rothenberg ME. New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting. J Allergy Clin Immunol 2018;142:48-53. [PMID: 29803797 DOI: 10.1016/j.jaci.2018.05.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
143 de Rooij WE, Bennebroek Evertsz' F, Lei A, Bredenoord AJ. Mental distress among adult patients with eosinophilic esophagitis. Neurogastroenterol Motil 2021;33:e14069. [PMID: 33382201 DOI: 10.1111/nmo.14069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
144 Ghisa M, Laserra G, Marabotto E, Ziola S, Tolone S, de Bortoli N, Frazzoni M, Mauro A, Penagini R, Savarino V, Barberio B, Giannini EG, Zentilin P, Gyawali CP, Savarino E. Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis. Clinical Gastroenterology and Hepatology 2021;19:1554-63. [DOI: 10.1016/j.cgh.2020.07.056] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
145 Votto M, Raffaele A, De Filippo M, Caimmi S, Brunero M, Riccipetitoni G, Marseglia GL, Licari A. Eosinophilic gastrointestinal disorders in children and adolescents: A single-center experience. Dig Liver Dis 2021:S1590-8658(21)00341-8. [PMID: 34274254 DOI: 10.1016/j.dld.2021.06.027] [Reference Citation Analysis]
146 Dellon ES, Gupta SK. A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis. Clin Gastroenterol Hepatol. 2019;17:2149-2160. [PMID: 30710696 DOI: 10.1016/j.cgh.2019.01.030] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
147 Posner S, Boyd A, Patel A. Dysphagia in a 34-Year-Old Woman. JAMA 2020;323:660-1. [PMID: 32003770 DOI: 10.1001/jama.2019.19121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Zheng P, Tan HY. New developments in diagnosis and treatment of eosinophilic esophagitis. Shijie Huaren Xiaohua Zazhi 2019; 27(13): 828-834 [DOI: 10.11569/wcjd.v27.i13.828] [Reference Citation Analysis]
149 Kinoshita Y, Oouchi S, Fujisawa T. Eosinophilic gastrointestinal diseases - Pathogenesis, diagnosis, and treatment. Allergol Int 2019;68:420-9. [PMID: 31000445 DOI: 10.1016/j.alit.2019.03.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 13.0] [Reference Citation Analysis]
150 Malone V, Sheahan K. Novel and rare forms of oesophagitis. Histopathology 2021;78:4-17. [PMID: 33382498 DOI: 10.1111/his.14284] [Reference Citation Analysis]
151 Ruffner MA, Kennedy K, Cianferoni A. Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications. Expert Rev Clin Immunol 2019;15:83-95. [PMID: 30394139 DOI: 10.1080/1744666X.2019.1544893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
152 Lucendo AJ. Drug treatment strategies for eosinophilic esophagitis in adults. Expert Opin Pharmacother 2022;:1-14. [PMID: 35379069 DOI: 10.1080/14656566.2022.2060077] [Reference Citation Analysis]
153 Renz H, Bachert C, Berek C, Hamelmann E, Levi-Schaffer F, Raap U, Simon HU, Ploetz S, Taube C, Valent P, Voehringer D, Werfel T, Zhang N, Ring J. Physiology and pathology of eosinophils: Recent developments: Summary of the Focus Workshop Organized by DGAKI. Scand J Immunol 2021;93:e13032. [PMID: 33624312 DOI: 10.1111/sji.13032] [Reference Citation Analysis]
154 Hirano I, Spechler SJ. Maintenance Topical Steroid Therapy in Eosinophilic Esophagitis: Not So Hard to Swallow Any More? Gastroenterology 2020;159:1653-5. [PMID: 32918912 DOI: 10.1053/j.gastro.2020.09.005] [Reference Citation Analysis]
155 Nguyen N, Kramer RE, Menard-Katcher C. Endoscopy in Pediatric Eosinophilic Esophagitis. Front Pediatr 2021;9:713027. [PMID: 34504816 DOI: 10.3389/fped.2021.713027] [Reference Citation Analysis]
156 Dellon ES, Lucendo AJ, Schlag C, Schoepfer AM, Falk GW, Eagle G, Nezamis J, Comer GM, Knoop K, Hirano I. Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial. Clin Gastroenterol Hepatol 2022:S1542-3565(22)00139-2. [PMID: 35181572 DOI: 10.1016/j.cgh.2022.02.013] [Reference Citation Analysis]
157 Hoofien A, Rea F, Espinheira MDC, Amil Dias J, Romano C, Oliva S, Auth MK, Zangen T, Kalach N, Domínguez-Ortega G, De Angelis P, Zevit N; ESPGHAN EGID Working Group. Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis. Dig Liver Dis 2021;53:324-8. [PMID: 33334703 DOI: 10.1016/j.dld.2020.11.025] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Jensen ET, Langefeld CD, Zimmerman KD, Howard TD, Dellon ES. Epigenetic methylation in Eosinophilic Esophagitis: Molecular ageing and novel biomarkers for treatment response. Clin Exp Allergy 2020;50:1372-80. [PMID: 32986922 DOI: 10.1111/cea.13748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
159 Hannan N, McMillan SS, Tiralongo E, Steel A. Treatment Burden for Pediatric Eosinophilic Esophagitis: A Cross-Sectional Survey of Carers. J Pediatr Psychol 2021;46:100-11. [PMID: 33216917 DOI: 10.1093/jpepsy/jsaa095] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Vanuytsel T. It takes one meeting to increase awareness of eosinophilic esophagitis. Endoscopy 2021;53:25-6. [PMID: 33333564 DOI: 10.1055/a-1243-0601] [Reference Citation Analysis]
161 Hannan N, Steel A, McMillan SS, Tiralongo E. Health Service Use and Treatment Choices for Pediatric Eosinophilic Esophagitis: Findings From a Cross-Sectional Survey of Australian Carers. Front Pediatr 2020;8:147. [PMID: 32363170 DOI: 10.3389/fped.2020.00147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
162 Sheedy K, Patel N, Porter J, Silva H. Cost and accessibility of empiric food elimination diets for treatment of eosinophilic oesophagitis. Nutr Diet 2021. [PMID: 34927796 DOI: 10.1111/1747-0080.12717] [Reference Citation Analysis]
163 Patel RV, Hirano I. New Developments in the Diagnosis, Therapy, and Monitoring of Eosinophilic Esophagitis. Curr Treat Options Gastroenterol 2018;16:15-26. [PMID: 29357016 DOI: 10.1007/s11938-018-0167-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
164 Larsson H, Attwood S. Eosinophilic esophagitis (EoE); a disease that must not be neglected - implications of esophageal rupture and its management. BMC Gastroenterol 2020;20:185. [PMID: 32527222 DOI: 10.1186/s12876-020-01330-y] [Reference Citation Analysis]
165 Rustagi S, Mullins D, Yanney E. Current updates in diagnosis and management of eosinophilic esophagitis. Curr Probl Pediatr Adolesc Health Care 2020;50:100783. [PMID: 32446911 DOI: 10.1016/j.cppeds.2020.100783] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
166 Robson J, O’gorman M, Mcclain A, Mutyala K, Davis C, Barbagelata C, Wheeler J, Firszt R, Smith K, Patel R, Peterson K, Lowichik A, Guthery S. Incidence and Prevalence of Pediatric Eosinophilic Esophagitis in Utah Based on a 5-Year Population-Based Study. Clinical Gastroenterology and Hepatology 2019;17:107-114.e1. [DOI: 10.1016/j.cgh.2018.06.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
167 Sher ER, Ross JA, Weine DM, Chandini Arjun A. Current and emerging therapies for eosinophilic esophagitis. Allergy Asthma Proc 2022;43:178-86. [PMID: 35524356 DOI: 10.2500/aap.2022.43.220014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Lyons E, Donohue K, Lee JJ. Developing Pharmacologic Treatments for Eosinophilic Esophagitis: Draft Guidance from the United States Food and Drug Administration. Gastroenterology 2019;157:275-7. [DOI: 10.1053/j.gastro.2019.04.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
169 Rojas Pineda N, Morfin Maciel B, Chanona-vilchis J. Throat clearing as the only symptom of eosinophilic esophagitis: A case report. Revista de Gastroenterología de México (English Edition) 2020;85:216-8. [DOI: 10.1016/j.rgmxen.2019.04.004] [Reference Citation Analysis]
170 Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, Falck-Ytter YT, Dellon ES; AGA Institute. Electronic address: clinicalpractice@gastro.org., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Electronic address: drdanawallace@gmail.com., AGA Institute., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology 2020;158:1789-1810.e15. [PMID: 32359563 DOI: 10.1053/j.gastro.2020.02.039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
171 Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM, Straumann A, Safroneeva E, Grimm M, Smith H, Tompkins CA, Woo A, Peach R, Frohna P, Gujrathi S, Penenberg DN, Li C, Opiteck GJ, Olson A, Aranda R, Rothenberg ME, Dellon ES; HEROES Study Group. RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. Gastroenterology. 2019;156:592-603.e10. [PMID: 30395812 DOI: 10.1053/j.gastro.2018.10.051] [Cited by in Crossref: 78] [Cited by in F6Publishing: 74] [Article Influence: 19.5] [Reference Citation Analysis]
172 Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES. Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease. Inflamm Intest Dis 2019;3:180-6. [PMID: 31111034 DOI: 10.1159/000497236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
173 Nennstiel S, Schlag C. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids. World J Gastroenterol 2020; 26(36): 5395-5407 [PMID: 33024392 DOI: 10.3748/wjg.v26.i36.5395] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Kim GH, Park YS, Jung KW, Kim M, Na HK, Ahn JY, Lee JH, Kim DH, Choi KD, Song HJ, Lee GH, Dellon ES, Jung HY. An Increasing Trend of Eosinophilic Esophagitis in Korea and the Clinical Implication of the Biomarkers to Determine Disease Activity and Treatment Response in Eosinophilic Esophagitis. J Neurogastroenterol Motil 2019;25:525-33. [PMID: 31587544 DOI: 10.5056/jnm19066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
175 Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol. 2019;17:647-656.e1. [PMID: 30099104 DOI: 10.1016/j.cgh.2018.07.043] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
176 Votto M, Castagnoli R, De Filippo M, Brambilla I, Cuppari C, Marseglia GL, Licari A. Behavioral issues and quality of life in children with eosinophilic esophagitis. Minerva Pediatr 2020;72. [DOI: 10.23736/s0026-4946.20.05913-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
177 Pasman EA, Ong B, Witmer CP, Nylund CM. Proton Pump Inhibitors in Children: the Good, the Bad, and the Ugly. Curr Allergy Asthma Rep 2020;20:39. [PMID: 32524278 DOI: 10.1007/s11882-020-00926-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Rossi CM, Lenti MV, Merli S, Santacroce G, Di Sabatino A. Allergic manifestations in autoimmune gastrointestinal disorders. Autoimmun Rev 2021;:102958. [PMID: 34560305 DOI: 10.1016/j.autrev.2021.102958] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
179 Fitzgerald RC, Vaezi MF. Esophageal Diseases. Gastroenterology 2018;154:263-6. [PMID: 29274867 DOI: 10.1053/j.gastro.2017.12.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
180 Miehlke S, Lucendo AJ, Straumann A, Jan Bredenoord A, Attwood S. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Therap Adv Gastroenterol 2020;13:1756284820927282. [PMID: 32565912 DOI: 10.1177/1756284820927282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
181 Visaggi P, Mariani L, Pardi V, Rosi EM, Pugno C, Bellini M, Zingone F, Ghisa M, Marabotto E, Giannini EG, Savarino V, Marchi S, Savarino EV, de Bortoli N. Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach. Nutrients 2021;13:1630. [PMID: 34066243 DOI: 10.3390/nu13051630] [Reference Citation Analysis]
182 Srinivasan S, Sundaram S, Kennedy KF, Kohli DR, Emura F, Sharma P, Desai M. Trends and predictors of 30-day readmissions in subjects with eosinophilic esophagitis: results from a national cohort. Dis Esophagus 2021:doab060. [PMID: 34510195 DOI: 10.1093/dote/doab060] [Reference Citation Analysis]
183 Kim JP, Kahrilas PJ. How I Approach Dysphagia. Curr Gastroenterol Rep 2019;21. [DOI: 10.1007/s11894-019-0718-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
184 Inage E, Furuta GT, Menard-Katcher C, Masterson JC. Eosinophilic esophagitis: pathophysiology and its clinical implications. Am J Physiol Gastrointest Liver Physiol 2018;315:G879-86. [PMID: 30212252 DOI: 10.1152/ajpgi.00174.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
185 Shah SC, Tepler A, Peek RM Jr, Colombel JF, Hirano I, Narula N. Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2019;17:2185-2198.e3. [PMID: 30659992 DOI: 10.1016/j.cgh.2019.01.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
186 Safroneeva E, Schoepfer AM. Symptom-based patient-reported outcomes in adults with eosinophilic esophagitis: value for treatment monitoring and randomized controlled trial design. Curr Opin Allergy Clin Immunol 2019;19:169-74. [PMID: 30649010 DOI: 10.1097/ACI.0000000000000514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
187 Tytgat GNJ. Gastro Update Europe 2018. Dig Dis 2019;37:175-87. [PMID: 30602161 DOI: 10.1159/000495705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
188 Eluri S, Iglesia EGA, Massaro M, Peery AF, Shaheen NJ, Dellon ES. Practice patterns and adherence to clinical guidelines for diagnosis and management of eosinophilic esophagitis among gastroenterologists. Dis Esophagus 2020:doaa025. [PMID: 32378700 DOI: 10.1093/dote/doaa025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
189 Oliva S, Dellon ES. Reversal of fibrosis in eosinophilic esophagitis: Another feather in the PPI cap? Dig Liver Dis 2021;53:1476-8. [PMID: 34531128 DOI: 10.1016/j.dld.2021.08.012] [Reference Citation Analysis]
190 . Ueg Week 2020 Poster Presentations. United European Gastroenterol j 2020;8:144-887. [DOI: 10.1177/2050640620927345] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
191 Schoepfer AM, Henchoz S, Biedermann L, Schreiner P, Greuter T, Reinhard A, Senn J, Franke A, Burri E, Juillerat P, Simon HU, Straumann A, Safroneeva E, Godat S. Technical feasibility, clinical effectiveness, and safety of esophageal stricture dilation using a novel endoscopic attachment cap in adults with eosinophilic esophagitis. Gastrointest Endosc 2021:S0016-5107(21)01352-3. [PMID: 34004192 DOI: 10.1016/j.gie.2021.05.017] [Reference Citation Analysis]
192 Bogale K, Stern H, Jhaveri P, Jhaveri P. Needs Assessment for Eosinophilic Esophagitis Education in School Nurses. J Sch Nurs 2021;:1059840520986746. [PMID: 33438514 DOI: 10.1177/1059840520986746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 De Matteis A, Pagliaro G, Corleto VD, Pacchiarotti C, Di Giulio E, Villa MP, Parisi P, Vassallo F, Ziparo C, Di Nardo G. Eosinophilic Esophagitis in Children: Clinical Findings and Diagnostic Approach. Curr Pediatr Rev 2020;16:206-14. [PMID: 31584371 DOI: 10.2174/1573396315666191004110549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
194 Kanikowska A, Hryhorowicz S, Rychter AM, Kucharski MA, Zawada A, Iwanik K, Eder P, Słomski R, Dobrowolska A, Krela-Kaźmierczak I. Immunogenetic, Molecular and Microbiotic Determinants of Eosinophilic Esophagitis and Clinical Practice-A New Perspective of an Old Disease. Int J Mol Sci 2021;22:10830. [PMID: 34639170 DOI: 10.3390/ijms221910830] [Reference Citation Analysis]
195 Carr S, Chan ES, Watson W. Correction to: Eosinophilic esophagitis. Allergy Asthma Clin Immunol 2019;15:22. [PMID: 31007687 DOI: 10.1186/s13223-019-0336-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
196 Biedermann L, Straumann A, Greuter T, Schreiner P. Eosinophilic esophagitis-established facts and new horizons. Semin Immunopathol 2021;43:319-35. [PMID: 34097125 DOI: 10.1007/s00281-021-00855-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Ruffner MA, Juste L, Muir AB. Medical Management of Eosinophilic Esophagitis in Pediatric Patients. Pediatr Clin North Am 2021;68:1191-204. [PMID: 34736584 DOI: 10.1016/j.pcl.2021.07.014] [Reference Citation Analysis]
198 Arias Á, Lucendo AJ. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice. Expert Review of Gastroenterology & Hepatology 2018;13:99-117. [DOI: 10.1080/17474124.2019.1546120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
199 Carr S, Chan ES, Watson W. Eosinophilic esophagitis. Allergy Asthma Clin Immunol 2018;14:58. [PMID: 30275848 DOI: 10.1186/s13223-018-0287-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
200 Chang JW, Chen VL, Rubenstein JH, Dellon ES, Wallner LP, De Vries R. What patients with eosinophilic esophagitis may not share with their providers: a qualitative assessment of online health communities. Dis Esophagus 2021:doab073. [PMID: 34718475 DOI: 10.1093/dote/doab073] [Reference Citation Analysis]
201 Ketchem CJ, Reed CC, Stefanadis Z, Dellon ES. Treatment with compounded fluticasone suspension improves the clinical, endoscopic, and histologic features of eosinophilic esophagitis. Dis Esophagus 2021;34:doaa120. [PMID: 33306783 DOI: 10.1093/dote/doaa120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
202 Rossi CM, Lenti MV, Merli S, Licari A, Votto M, Marseglia GL, Di Sabatino A. Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications. Clin Transl Allergy 2022;12:e12146. [PMID: 35620572 DOI: 10.1002/clt2.12146] [Reference Citation Analysis]
203 Naik RD, Patel DA. Unlocking the Mind Might Be Critical in Management of Eosinophilic Esophagitis: Expanding Beyond Drugs, Dilation, and Diet. Gastroenterology 2021:S0016-5085(21)03283-2. [PMID: 34314683 DOI: 10.1053/j.gastro.2021.07.032] [Reference Citation Analysis]
204 Rossetti D, Isoldi S, Oliva S. Eosinophilic Esophagitis: Update on Diagnosis and Treatment in Pediatric Patients. Paediatr Drugs 2020;22:343-56. [PMID: 32519266 DOI: 10.1007/s40272-020-00398-z] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
205 Vieira MC, Gugelmin ES, Percicote AP, Ribeiro MG, de Miranda RA, Vieira GG, Ribeiro LBM, Truppel SK, Filho NAR. Intra- and interobserver agreement of histopathological findings in pediatric patients with eosinophilic esophagitis. J Pediatr (Rio J) 2021:S0021-7557(21)00057-7. [PMID: 33964213 DOI: 10.1016/j.jped.2021.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
206 Lam AY, Ma C, Lee JK, Bredenoord AJ. Eosinophilic esophagitis: New molecules, better life? Curr Opin Pharmacol 2022;63:102183. [PMID: 35176546 DOI: 10.1016/j.coph.2022.102183] [Reference Citation Analysis]
207 Główczewski A, Krogulska A. Formulations of Topical Steroids in Eosinophilic Esophagitis-Current Treatment and Emerging Possibilities. J Clin Med 2022;11:1454. [PMID: 35268544 DOI: 10.3390/jcm11051454] [Reference Citation Analysis]
208 Colizzo J, Clayton S, Kumar A, Richter J. Intrabolus Pressure Has Better Correlation Than Eosinophilia with Dysphagia Severity in Fibrostenotic Eosinophilic Esophagitis: A Pilot Study. GastrointestDisord 2018;1:3-14. [DOI: 10.3390/gidisord1010002] [Reference Citation Analysis]
209 Feo-ortega S, Lucendo AJ. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician. Therap Adv Gastroenterol 2022;15:175628482110686. [DOI: 10.1177/17562848211068665] [Reference Citation Analysis]
210 Ishimura N, Okimoto E, Shibagaki K, Nagano N, Ishihara S. Similarity and difference in the characteristics of eosinophilic esophagitis between Western countries and Japan. Dig Endosc 2021;33:708-19. [PMID: 32623781 DOI: 10.1111/den.13786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
211 Hirano I, Safroneeva E, Roumet MC, Comer GM, Eagle G, Schoepfer A, Falk GW. Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis. Aliment Pharmacol Ther 2020;51:750-9. [PMID: 32149424 DOI: 10.1111/apt.15670] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
212 Mintz MJ, Ananthakrishnan AN. Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis. Inflamm Bowel Dis 2021;27:469-75. [PMID: 32430501 DOI: 10.1093/ibd/izaa094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Gargano D, Appanna R, Santonicola A, De Bartolomeis F, Stellato C, Cianferoni A, Casolaro V, Iovino P. Food Allergy and Intolerance: A Narrative Review on Nutritional Concerns. Nutrients 2021;13:1638. [PMID: 34068047 DOI: 10.3390/nu13051638] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
214 Röjler L, Glimberg I, Walker MM, Garber JJ, Ludvigsson JF. Validation of the diagnosis of eosinophilic esophagitis based on histopathology reports in Sweden. Ups J Med Sci 2021;126. [PMID: 34471483 DOI: 10.48101/ujms.v126.7687] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, Falck-Ytter YT, Dellon ES; AGA Institute. Electronic address: clinicalpractice@gastro.org., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Electronic address: drdanawallace@gmail.com., AGA Institute., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters. Ann Allergy Asthma Immunol 2020;124:424-440.e17. [PMID: 32336463 DOI: 10.1016/j.anai.2020.03.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
216 Chang N, Raja S, Betancourt R, Randall C, Keene S, Lilly A, Fowler M, Woosley JT, Shaheen NJ, Dellon ES. Generic Measures of Quality of Life Are Not Correlated with Disease Activity in Eosinophilic Esophagitis. Dig Dis Sci 2021. [PMID: 33492534 DOI: 10.1007/s10620-020-06719-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Bushyhead D, Dorer RK, Gluck M. An Unexpected Consequence of a Clinical Trial. Gastroenterology 2019;157:944-5. [DOI: 10.1053/j.gastro.2018.12.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
218 Woo W, Aceves SS. The role of the allergist in the management of eosinophilic esophagitis. Curr Opin Gastroenterol 2021;37:390-6. [PMID: 34059605 DOI: 10.1097/MOG.0000000000000746] [Reference Citation Analysis]
219 Bashaw H, Schwartz S, Kagalwalla AF, Wechsler JB. Tutorial: Nutrition Therapy in Eosinophilic Esophagitis—Outcomes and Deficiencies. Journal of Parenteral and Enteral Nutrition 2020;44:600-9. [DOI: 10.1002/jpen.1738] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
220 Fujiwara Y, Tanoue K, Higashimori A, Nishida Y, Maruyama M, Itani S, Ominami M, Nadatani Y, Fukunaga S, Otani K, Hosomi S, Tanaka F, Kamata N, Nagami Y, Taira K, Machida H, Tanigawa T, Watanabe T, Ohsawa M; F-Study group . Endoscopic findings of gastric lesions in patients with eosinophilic gastrointestinal disorders. Endosc Int Open 2020;8:E1817-25. [PMID: 33269315 DOI: 10.1055/a-1268-7312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Dellon ES, Khoury P, Muir AB, Liacouras CA, Safroneeva E, Atkins D, Collins MH, Gonsalves N, Falk GW, Spergel JM, Hirano I, Chehade M, Schoepfer AM, Menard-katcher C, Katzka DA, Bonis PA, Bredenoord AJ, Geng B, Jensen ET, Pesek RD, Feuerstadt P, Gupta SK, Lucendo AJ, Genta RM, Hiremath G, Mcgowan EC, Moawad FJ, Peterson KA, Rothenberg ME, Straumann A, Furuta GT, Aceves SS. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions. Journal of Allergy and Clinical Immunology 2022. [DOI: 10.1016/j.jaci.2022.03.015] [Reference Citation Analysis]
222 Dellon ES. Editorial: the evolving epidemiology of EoE-up, up, and away? Aliment Pharmacol Ther 2019;49:1448-9. [PMID: 31074899 DOI: 10.1111/apt.15252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
223 Visaggi P, Ghisa M, Barberio B, Maniero D, Greco E, Savarino V, Black CJ, Ford AC, de Bortoli N, Savarino E. Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.05.004] [Reference Citation Analysis]
224 Moore H, Wechsler J, Frost C, Whiteside E, Baldassano R, Markowitz J, Muir AB. Comorbid Diagnosis of Eosinophilic Esophagitis and Inflammatory Bowel Disease in the Pediatric Population. J Pediatr Gastroenterol Nutr 2021;72:398-403. [PMID: 33230079 DOI: 10.1097/MPG.0000000000003002] [Reference Citation Analysis]
225 Young E, Philpott H. Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management. Dig Dis Sci 2022. [PMID: 35230577 DOI: 10.1007/s10620-022-07419-6] [Reference Citation Analysis]
226 Tedner SG, Asarnoj A, Thulin H, Westman M, Konradsen JR, Nilsson C. Food allergy and hypersensitivity reactions in children and adults-A review. J Intern Med 2021. [PMID: 34875122 DOI: 10.1111/joim.13422] [Reference Citation Analysis]
227 Genta RM, Dellon ES, Turner KO. Non-oesophageal eosinophilic gastrointestinal diseases are undersuspected clinically and underdiagnosed pathologically. Aliment Pharmacol Ther 2022;56:240-50. [PMID: 35546318 DOI: 10.1111/apt.16971] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 McGowan EC, Keller JP, Dellon ES, Peng R, Keet CA. Prevalence and geographic distribution of pediatric eosinophilic esophagitis in the 2012 US Medicaid population. J Allergy Clin Immunol Pract 2020;8:2796-2798.e4. [PMID: 32320795 DOI: 10.1016/j.jaip.2020.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
229 Lee K, Choe BH, Kang B, Kim S, Kim JY, Shim JO, Lee YM, Lee EH, Jang HJ, Ryoo E, Yang HR. Nationwide Multicenter Study of Eosinophilic Esophagitis in Korean Children. Pediatr Gastroenterol Hepatol Nutr 2020;23:231-42. [PMID: 32483544 DOI: 10.5223/pghn.2020.23.3.231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
230 Ackerman SJ, Kagalwalla AF, Hirano I, Gonsalves N, Katcher PM, Gupta S, Wechsler JB, Grozdanovic M, Pan Z, Masterson JC, Du J, Fantus RJ, Alumkal P, Lee JJ, Ochkur S, Ahmed F, Capocelli K, Melin-Aldana H, Biette K, Dubner A, Amsden K, Keeley K, Sulkowski M, Zalewski A, Atkins D, Furuta GT. One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis. Am J Gastroenterol 2019;114:1614-25. [PMID: 31567192 DOI: 10.14309/ajg.0000000000000371] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
231 Gomez Torrijos E, Gonzalez-Mendiola R, Alvarado M, Avila R, Prieto-Garcia A, Valbuena T, Borja J, Infante S, Lopez MP, Marchan E, Prieto P, Moro M, Rosado A, Saiz V, Somoza ML, Uriel O, Vazquez A, Mur P, Poza-Guedes P, Bartra J. Eosinophilic Esophagitis: Review and Update. Front Med (Lausanne) 2018;5:247. [PMID: 30364207 DOI: 10.3389/fmed.2018.00247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]